Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
CLOROX CO /DE/
Next earnings ≈ Jul 30, 2026 · est. from filing cadence
Last earnings +1.8% on 2026-04-30
Healthy net margin (11.4%); but high leverage (liabilities/equity 15.8x).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
CLOROX CO /DE/ shows $7.10B in FY2025 revenue (+0.2% YoY), a 11.4% net margin, and 252.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000021076, latest 10-Q filed 2026-04-30) · EODHD · rules-based read · as of 6/17/2026, 6:07:56 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $7.34B | $7.11B | $7.39B | $7.09B | $7.10B |
| Gross profit | $3.20B | $2.54B | $2.91B | $3.05B | $3.21B |
| Operating income | — | — | — | — | — |
| Net income | $710M | $462M | $149M | $280M | $810M |
| Diluted EPS | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 |
| Net margin | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
34 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 1 open-market buy · 0 sales
| 2026-05-05 | Breber Pierre R Director | Buy | 5.00K @ $85.82 | $429K |
| 2026-04-01 | Bellet Luc EVP - Chief Financial Officer | Tax | 244.00 @ $103.63 | $25.3K |
| 2026-03-13 | Hyder Chris T EVP-Group Pres -Hlth & Hyg | Tax | 41.00 @ $108.73 | $4.46K |